News|Articles|May 15, 2016

Pharmaceutical Technology

  • Pharmaceutical Technology-05-15-2016
  • Volume 2016 eBook
  • Issue 2

Measuring and Removing Genotoxic Impurities

Author(s)Agnes Shanley

Electrophilic and other reactive compounds, and their precursors, must be measured and removed to ensure patient safety.

Electrophilic and other reactive compounds, and their precursors, must be measured and removed to ensure patient safety.

Download

Pharmaceutical Technology’s 2016 Bioprocessing and Sterile Manufacturing eBook

.

 

 

Articles in this issue

over 9 years ago

Qualification and Validation of Single-Use Shipping Systems

over 9 years ago

The Evolution of Planning, Design, and Engineering—Flexibility Takes Center Stage

over 9 years ago

Revised ISO Cleanroom Standards Improve Air Cleanliness Classification

over 9 years ago

Lessons Learned Accelerate Vaccine Development

over 9 years ago

Protecting the Product and the Patient

over 9 years ago

Deconstructing the Regulatory Spiral

over 9 years ago

Non-Sterile is Non-Sterile: A Reality Check on Microbial Control Expectations

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content